Juvia-M Plus 50/500mg Tablet

Juvia-M Plus 50/500mg Tablet is a combination medication containing two active ingredients: sitagliptin and metformin. Sitagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, while metformin is a biguanide antidiabetic agent. This combination is prescribed for the management of type 2 diabetes mellitus by targeting multiple pathways involved in glucose metabolism. Sitagliptin works by increasing the levels of incretin hormones, which stimulate insulin release and decrease glucagon secretion, while metformin improves insulin sensitivity, reduces glucose production in the liver, and enhances glucose uptake in peripheral tissues.

Uses:

Juvia-M Plus 50/500mg Tablet is indicated for the following purposes:

• Management of type 2 diabetes mellitus: The combination of sitagliptin and metformin helps lower blood sugar levels by complementary mechanisms of action, leading to improved glycemic control in adults with type 2 diabetes mellitus.
• Prevention of cardiovascular events: In addition to its glucose-lowering effects, sitagliptin has been shown to reduce the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.

By effectively lowering blood sugar levels and mitigating cardiovascular risk, Juvia-M Plus Tablet helps improve overall health outcomes in diabetic individuals.

Side Effects:

While Juvia-M Plus 50/500mg Tablet is generally well-tolerated, some individuals may experience side effects related to sitagliptin, metformin, or both components, including:

• Gastrointestinal discomfort (such as nausea, diarrhea, or abdominal pain)
• Hypoglycemia (low blood sugar) when used in combination with insulin or insulin secretagogues
• Lactic acidosis (rare but serious complication associated with metformin use)
• Upper respiratory tract infections
• Headache

If you experience any severe or persistent side effects, inform your healthcare provider promptly.

Precautions:

• Inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking before starting Juvia-M Plus 50/500mg Tablet.
• Monitor blood sugar levels regularly, as instructed by your doctor, to ensure optimal glycemic control while on combination therapy.
• Exercise caution in patients with renal impairment or hepatic dysfunction, as metformin may accumulate and increase the risk of adverse effects in these populations.

When Not to Use:

Juvia-M Plus 50/500mg Tablet should not be used in individuals with:

• Type 1 diabetes mellitus
• Diabetic ketoacidosis
• Severe renal impairment or end-stage renal disease
• History of hypersensitivity to sitagliptin, metformin, or any other components of the tablet

FAQ:

1. How should Juvia-M Plus 50/500mg Tablet be taken? Take Juvia-M Plus 50/500mg Tablet orally, with meals, as directed by your healthcare provider. Swallow the tablet whole with a glass of water, and do not crush, chew, or break it.
2. Are there any dietary restrictions while taking Juvia-M Plus 50/500mg Tablet? While there are no specific dietary restrictions, it is essential to follow a balanced diet and maintain healthy eating habits as part of overall diabetes management. Consult with a registered dietitian or healthcare provider for personalized dietary recommendations.
3. Can Juvia-M Plus 50/500mg Tablet be used during pregnancy or breastfeeding? Juvia-M Plus 50/500mg Tablet is not recommended for use during pregnancy or breastfeeding. Consult with your healthcare provider for alternative treatment options if you are pregnant, planning to become pregnant, or breastfeeding.
4. Can Juvia-M Plus 50/500mg Tablet be used in elderly patients? Juvia-M Plus 50/500mg Tablet can be used in elderly patients with type 2 diabetes mellitus, but caution should be exercised due to the increased risk of adverse effects, especially in patients with comorbidities. Close monitoring is recommended.